Insider Trading Alert - NHI, DYN And FICO Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.

Yesterday, May 14, 2015, 102 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $67.14 to $168,133,945.20.

Highlighted Stocks Traded by Insiders:

National Health Investors (NHI) - FREE Research Report

Jobe James R, who is Director at National Health Investors, bought 200 shares at $66.37 on May 14, 2015. Following this transaction, the Director owned 4,225 shares meaning that the stake was boosted by 4.97% with the 200-share transaction.

Mendelsohn D. Eric, who is EVP - Corporate Finance at National Health Investors, bought 1,500 shares at $65.77 on May 14, 2015. Following this transaction, the EVP - Corporate Finance owned 1,500 shares meaning that the stake was boosted by 100% with the 1,500-share transaction.

The shares most recently traded at $67.61, up $1.84, or 2.72% since the insider transaction. Historical insider transactions for National Health Investors go as follows:

  • 4-Week # shares bought: 398
  • 4-Week # shares sold: 5,950
  • 12-Week # shares bought: 398
  • 12-Week # shares sold: 5,950
  • 24-Week # shares bought: 398
  • 24-Week # shares sold: 5,950

The average volume for National Health Investors has been 171,200 shares per day over the past 30 days. National Health Investors has a market cap of $2.5 billion and is part of the financial sector and real estate industry. Shares are down 5.6% year-to-date as of the close of trading on Thursday.

National Health Investors Inc. is a real estate investment trust. It invests in the real estate markets of United States. The firm invests in the health care properties primarily in the long-term care and senior housing industries. The stock currently has a dividend yield of 5.2%. The company has a P/E ratio of 21.0. Currently, there is 1 analyst who rates National Health Investors a buy, no analysts rate it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on NHI - FREE

TheStreet Quant Ratings rates National Health Investors as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, expanding profit margins and increase in stock price during the past year. We feel its strengths outweigh the fact that the company has had sub par growth in net income. Get the full National Health Investors Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Dynegy (DYN) - FREE Research Report

Flexon Robert C, who is President and CEO at Dynegy, bought 20,000 shares at $32.48 on May 14, 2015. Following this transaction, the President and CEO owned 421,871 shares meaning that the stake was boosted by 4.98% with the 20,000-share transaction.

Freeland Clint, who is Exec. VP and CFO at Dynegy, bought 3,250 shares at $32.30 on May 14, 2015. Following this transaction, the Exec. VP and CFO owned 69,894 shares meaning that the stake was boosted by 4.88% with the 3,250-share transaction.

The shares most recently traded at $19.04, down $13.26, or 69.64% since the insider transaction. Historical insider transactions for Dynegy go as follows:

  • 4-Week # shares bought: 3,583
  • 12-Week # shares bought: 3,583
  • 24-Week # shares bought: 3,583

The average volume for Dynegy has been 1.6 million shares per day over the past 30 days. Dynegy has a market cap of $72.5 million and is part of the utilities sector and utilities industry. Shares are unchanged year-to-date as of the close of trading on Friday.

Dynegy Inc., through its subsidiaries, produces and sells electric energy, capacity, and ancillary services in the United States. It operates in three segments, Coal, IPH, and Gas. The company sells its services on a wholesale basis from its power generation facilities.

Exclusive Offer: Get the latest Stock Analysis on DYN - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Fair Isaac (FICO) - FREE Research Report

Deal Richard, who is Sr. Vice President at Fair Isaac, sold 12,923 shares at $87.01 on May 14, 2015. Following this transaction, the Sr. Vice President owned 16,347 shares meaning that the stake was reduced by 44.15% with the 12,923-share transaction.

The shares most recently traded at $88.35, up $1.34, or 1.51% since the insider transaction. Historical insider transactions for Fair Isaac go as follows:

  • 4-Week # shares bought: 8,000
  • 4-Week # shares sold: 3,000
  • 12-Week # shares bought: 8,000
  • 12-Week # shares sold: 3,000
  • 24-Week # shares bought: 8,000
  • 24-Week # shares sold: 3,000

The average volume for Fair Isaac has been 217,600 shares per day over the past 30 days. Fair Isaac has a market cap of $2.7 billion and is part of the technology sector and computer software & services industry. Shares are up 19.82% year-to-date as of the close of trading on Thursday.

Fair Isaac Corporation provides analytic, software, and data management products and services that enable businesses to automate, enhance, and connect decisions to enhance business performance worldwide. The stock currently has a dividend yield of 0.09%. The company has a P/E ratio of 31.6. Currently, there are 2 analysts who rate Fair Isaac a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on FICO - FREE

TheStreet Quant Ratings rates Fair Isaac as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, solid stock price performance and expanding profit margins. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full Fair Isaac Ratings Report from TheStreet Quant Ratings now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

More from Markets

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Sohn Conference Briefly Distracts From Barrage of Earnings -- ICYMI

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Dow and Nasdaq Finish Lower as 10-Year Treasury Yield Hovers Near 3%

Video: Stop Using Student Loan Money to Buy Bitcoin

Video: Stop Using Student Loan Money to Buy Bitcoin

Let the Najarian Brothers Crash-Proof Portfolio

Let the Najarian Brothers Crash-Proof Portfolio

Facebook Sends Facial Recognition Notification in Error

Facebook Sends Facial Recognition Notification in Error